Clinical Trial Update: Neoadjuvant and Adjuvant Checkpoint Blockade [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant and adjuvant checkpoint blockade trial in melanoma completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Mucosal Melanoma
• Ocular Melanoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cutaneous Melanoma, Mucosal Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2024-04-05